HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Yazhou Li Selected Research

Biomarkers (Surrogate Marker)

5/2017Insulin resistance and exendin-4 treatment for multiple system atrophy.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Yazhou Li Research Topics

Disease

14Type 2 Diabetes Mellitus (MODY)
05/2024 - 01/2009
13Parkinson Disease (Parkinson's Disease)
04/2024 - 01/2009
12Neoplasms (Cancer)
03/2024 - 01/2003
11Alzheimer Disease (Alzheimer's Disease)
01/2019 - 05/2008
10Neurodegenerative Diseases (Neurodegenerative Disease)
03/2024 - 06/2010
8Brain Concussion (Cerebral Concussion)
01/2020 - 10/2013
7Neuroinflammatory Diseases
04/2024 - 10/2009
7Cognitive Dysfunction
11/2022 - 07/2012
7Stroke (Strokes)
04/2019 - 01/2009
6Traumatic Brain Injuries (Traumatic Brain Injury)
04/2019 - 01/2013
5Inflammation (Inflammations)
11/2020 - 10/2009
4Nervous System Diseases (Neurological Disorders)
05/2024 - 07/2012
4Infections
04/2023 - 10/2019
4Neuroblastoma
12/2021 - 06/2010
3Obesity
05/2024 - 01/2020
3Neoplasm Metastasis (Metastasis)
03/2024 - 01/2014
3Insulin Resistance
05/2017 - 10/2003
2Carcinogenesis
03/2024 - 01/2017
2Lung Neoplasms (Lung Cancer)
10/2023 - 06/2020
2Wounds and Injuries (Trauma)
08/2022 - 12/2015
2Hemorrhage
08/2022 - 03/2007
2Disease Progression
04/2021 - 05/2012
2Fibrosis (Cirrhosis)
11/2020 - 10/2017
2Liver Neoplasms (Liver Cancer)
06/2020 - 06/2020
2Cerebrovascular Disorders (Cerebrovascular Occlusion)
04/2019 - 07/2012
2Multiple System Atrophy
01/2019 - 05/2017
2Blast Injuries
01/2016 - 02/2014
1Weight Loss (Weight Reduction)
05/2024
1Hypertrophic Cardiomyopathy (Hypertrophic Obstructive Cardiomyopathy)
02/2024
1Reperfusion Injury
12/2023
1Autosomal Dominant Optic Atrophy (Dominant Optic Atrophy)
12/2023
1Hematologic Neoplasms (Hematological Malignancy)
09/2023
1Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung)
07/2023
1Esophageal Neoplasms (Esophageal Cancer)
04/2023
1Soft Tissue Infections
01/2023
1Sepsis (Septicemia)
01/2023
1Hyperplasia
01/2023
1Pseudotumor Cerebri (Idiopathic Intracranial Hypertension)
01/2023
1Intestinal Obstruction (Obstruction, Intestinal)
11/2022
1Ileus
11/2022
1Pathologic Constriction (Stenosis)
08/2022
1Pyloric Stenosis
08/2022
1Hemorrhagic Shock
08/2022
1Colorectal Neoplasms (Colorectal Cancer)
08/2022

Drug/Important Bio-Agent (IBA)

20Glucagon-Like Peptide 1 (GLP 1)IBA
05/2024 - 06/2010
17Exenatide (Byetta)FDA Link
01/2023 - 01/2003
9IncretinsIBA
03/2024 - 06/2010
9Glucagon-Like Peptide-1 ReceptorIBA
01/2023 - 01/2009
7Neuroprotective AgentsIBA
12/2021 - 12/2015
7Glucose (Dextrose)FDA LinkGeneric
11/2020 - 10/2003
5CytokinesIBA
06/2020 - 01/2003
5Peptides (Polypeptides)IBA
01/2020 - 09/2006
4Glucagon-Like Peptide-1 Receptor AgonistsIBA
05/2024 - 02/2014
3Insulin (Novolin)FDA Link
05/2024 - 10/2003
3Oxidopamine (6 Hydroxydopamine)IBA
04/2024 - 07/2018
3Glucagon (Glukagon)FDA Link
01/2020 - 10/2003
3Proteins (Proteins, Gene)FDA Link
01/2017 - 01/2011
3Cholinesterase Inhibitors (Anticholinesterases)IBA
01/2016 - 05/2008
3Cholinergic Agents (Cholinergics)IBA
01/2016 - 05/2008
3Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA
05/2012 - 10/2009
2Sitagliptin Phosphate (Januvia)FDA Link
04/2024 - 03/2024
2Dopamine (Intropin)FDA LinkGeneric
04/2024 - 01/2009
2Nucleic AcidsIBA
01/2023 - 10/2022
2Amyloid (Amyloid Fibrils)IBA
11/2022 - 01/2013
2Glutamic Acid (Glutamate)FDA Link
12/2021 - 02/2017
2SynucleinsIBA
01/2021 - 05/2017
2calloseIBA
01/2020 - 10/2019
2Delayed-Action PreparationsIBA
09/2018 - 07/2018
2phenserineIBA
01/2016 - 01/2013
2Blood Glucose (Blood Sugar)IBA
01/2013 - 01/2009
2LipopolysaccharidesIBA
05/2012 - 01/2011
2Hormones (Hormone)IBA
01/2011 - 06/2010
1Dipeptidyl-Peptidase IV InhibitorsIBA
04/2024
1Dipeptidyl Peptidase 4 (Dipeptidyl Peptidase IV)IBA
04/2024
1benzeneboronic acidIBA
03/2024
1Contrast MediaIBA
03/2024
1LigandsIBA
03/2024
1Metoprolol (Toprol-XL)FDA LinkGeneric
02/2024
1Uncoupling Protein 1IBA
12/2023
1ras ProteinsIBA
11/2023
1Protein Kinases (Protein Kinase)IBA
11/2023
1Protons (Proton)IBA
10/2023
1CyclohexaneIBA
09/2023
1IndazolesIBA
09/2023
1Tyrosine Kinase InhibitorsIBA
07/2023
1Immune Checkpoint InhibitorsIBA
07/2023
1ErbB Receptors (EGF Receptor)IBA
07/2023
1Anti-Bacterial Agents (Antibiotics)IBA
01/2023
1Small Interfering RNA (siRNA)IBA
10/2022
1Hemoglobins (Hemoglobin)IBA
08/2022

Therapy/Procedure

11Therapeutics
01/2023 - 01/2017
3Precision Medicine
01/2023 - 01/2020
2Decompression
04/2023 - 11/2022
2Enteral Nutrition (Feeding, Tube)
04/2023 - 08/2022
2Nutritional Support (Artificial Feeding)
04/2023 - 08/2022
2Catheters
11/2022 - 08/2022
2Palliative Care (Palliative Therapy)
11/2022 - 08/2022
1Oral Administration
03/2024
1Transplantation
12/2023
1Conservative Treatment
04/2023